Cartesian Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Cartesian Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$26.7M, a 26.4% increase year-over-year.
  • Cartesian Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$43.9M, a 49.2% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$43.9M, a 49.2% increase from 2023.
  • Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$86.4M, a 694% decline from 2022.
  • Cartesian Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $14.5M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$43.9M +$42.5M +49.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$86.4M -$101M -694% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $14.5M +$19.1M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$4.6M +$52.2M +91.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$56.8M -$4.37M -8.32% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$52.5M +$12.6M +19.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 -$65M -$1.24M -1.94% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$63.8M -$29.1M -84% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$34.7M -$9.37M -37% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$25.3M -$9.91M -64.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$15.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.